How Duncan was paid
$3.3M in total for 2025, as reported in the Summary Compensation Table. Equity awards are valued at grant, not at what they turned out to be worth.
Named executive officers
| Executive | Salary | Options | Incentive | Other | Total |
|---|---|---|---|---|---|
| Greg DuncanChairman and Chief Executive Officer | $577,003 | $2,400,598 | $317,352 | $49,775 | $3,344,728 |
| R. Michael Gendreau, MD, PhDChief Medical Officer | $366,082 | $779,142 | $146,433 | $38,620 | $1,330,277 |
| Angela WalshChief Financial Officer | $300,910 | $779,142 | $128,761 | $43,238 | $1,252,051 |
What changed and why
- $3.3MCEO total compensation increased to $3,344,728 in 2025 from $881,220 in 2024.
- $2.4MOption awards for the CEO rose to $2,400,598 reflecting annual grants.
- $317KNon-equity incentive compensation for the CEO was paid at $317,352 based on corporate targets.
- Stockholders approved the Second Amended and Restated 2020 Equity Incentive Plan increasing shares.
About this page
Figures are automated and can be wrong; check the filing for the exact numbers. Totals follow SEC rules, which value stock and option awards at grant. Read the DEF 14A proxy statement for footnotes and the compensation committee's full reasoning.